{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:35:00Z","timestamp":1768271700438,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901292"],"award-info":[{"award-number":["81901292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071183"],"award-info":[{"award-number":["82071183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2502100"],"award-info":[{"award-number":["2021YFC2502100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-06020-x","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:23:12Z","timestamp":1735582992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Taltirelin induces TH expression by regulating TRHR and RAR\u03b1 in medium spiny neurons"],"prefix":"10.1186","volume":"22","author":[{"given":"Kedong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanxia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"6020_CR1","doi-asserted-by":"publisher","DOI":"10.7726\/ajad.2013.1003","author":"CM Daimon","year":"2013","unstructured":"Daimon CM, Chirdon P, Maudsley S, Martin B. The role of thyrotropin releasing hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis. 2013. https:\/\/doi.org\/10.7726\/ajad.2013.1003.","journal-title":"Am J Alzheimers Dis"},{"key":"6020_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116927","volume":"415","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Tsutsumi R, Shimizu K, Tominaga N, Nagai M, Ugawa Y, et al. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration. J Neurol Sci. 2020;415: 116927.","journal-title":"J Neurol Sci"},{"key":"6020_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuropharm.2014.09.024","volume":"89","author":"JA Kelly","year":"2015","unstructured":"Kelly JA, Boyle NT, Cole N, Slator GR, Colivicchi MA, Stefanini C, et al. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Neuropharmacology. 2015;89:193\u2013203.","journal-title":"Neuropharmacology"},{"key":"6020_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105219","volume":"128","author":"F Duval","year":"2021","unstructured":"Duval F, Mokrani M-C, Erb A, Danila V, Lopera FG, Foucher JR, et al. Thyroid axis activity and dopamine function in depression. Psychoneuroendocrinology. 2021;128: 105219.","journal-title":"Psychoneuroendocrinology"},{"key":"6020_CR5","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.3390\/ijms241311047","volume":"24","author":"E Alvarez-Salas","year":"2023","unstructured":"Alvarez-Salas E, Garc\u00eda-Luna C, de Gortari P. New efforts to demonstrate the successful use of TRH as a therapeutic agent. Int J Mol Sci. 2023;24:11047.","journal-title":"Int J Mol Sci"},{"key":"6020_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.npep.2010.08.004","volume":"44","author":"L Jaworska-Feil","year":"2010","unstructured":"Jaworska-Feil L, Jantas D, Leskiewicz M, Budziszewska B, Kubera M, Basta-Kaim A, et al. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. Neuropeptides. 2010;44:495\u2013508.","journal-title":"Neuropeptides"},{"key":"6020_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013861","volume":"5","author":"I Cantuti-Castelvetri","year":"2010","unstructured":"Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR, et al. Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats. PLoS ONE. 2010;5: e13861.","journal-title":"PLoS ONE"},{"key":"6020_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.nbd.2012.07.012","volume":"48","author":"I Espadas","year":"2012","unstructured":"Espadas I, Darmopil S, Verga\u00f1o-Vera E, Ortiz O, Oliva I, Vicario-Abej\u00f3n C, et al. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: Insights into regulation and function. Neurobiol Dis. 2012;48:271\u201381.","journal-title":"Neurobiol Dis"},{"key":"6020_CR9","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.celrep.2018.07.053","volume":"24","author":"AB Mu\u00f1oz-Manchado","year":"2018","unstructured":"Mu\u00f1oz-Manchado AB, Gonzales CB, Zeisel A, Munguba H, Bekkouche B, Skene NG, et al. Diversity of interneurons in the dorsal striatum revealed by single-cell RNA sequencing and PatchSeq. Cell Rep. 2018;24:2179-2190.e7.","journal-title":"Cell Rep"},{"key":"6020_CR10","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1517\/13543776.2011.623127","volume":"21","author":"KS Khomane","year":"2011","unstructured":"Khomane KS, Meena CL, Jain R, Bansal AK. Novel thyrotropin-releasing hormone analogs: a patent review. Expert Opin Ther Pat. 2011;21:1673\u201391.","journal-title":"Expert Opin Ther Pat"},{"key":"6020_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1254\/fpj.110.supplement_33","volume":"110","author":"M Yamamura","year":"1997","unstructured":"Yamamura M, Suzuki M, Matsumoto K. Synthesis and pharmacological action of TRH analog peptide(Taltirelin). Folia Pharmacologica Japonica. 1997;110:33\u20138.","journal-title":"Folia Pharmacologica Japonica"},{"key":"6020_CR12","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1021\/jm00170a014","volume":"33","author":"M Suzuki","year":"1990","unstructured":"Suzuki M, Sugano H, Matsumoto K, Yamamura M, Ishida R. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. J Med Chem. 1990;33:2130\u20137.","journal-title":"J Med Chem"},{"key":"6020_CR13","first-page":"1389","volume":"4","author":"WM Brown","year":"2001","unstructured":"Brown WM. Taltirelin (Tanabe Seiyaku). IDrugs. 2001;4:1389\u2013400.","journal-title":"IDrugs"},{"key":"6020_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijiaratnam","year":"2021","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson\u2019s disease. The Lancet Neurology. 2021;20:559\u201372.","journal-title":"The Lancet Neurology"},{"key":"6020_CR15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. The Lancet. 2021;397:2284\u2013303.","journal-title":"The Lancet"},{"key":"6020_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-0716-1712-0_7","volume-title":"Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice","author":"A Surguchov","year":"2022","unstructured":"Surguchov A. Biomarkers in Parkinson\u2019s Disease. In: Peplow PV, Martinez B, Gennarelli TA, editors. Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice. Springer, US: New York NY; 2022. p. 155\u201380."},{"key":"6020_CR17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science. 2017;357:1255\u201361.","journal-title":"Science"},{"key":"6020_CR18","doi-asserted-by":"publisher","first-page":"20140184","DOI":"10.1098\/rstb.2014.0184","volume":"370","author":"P Calabresi","year":"2015","unstructured":"Calabresi P, Ghiglieri V, Mazzocchetti P, Corbelli I, Picconi B. Levodopa-induced plasticity: a double-edged sword in Parkinson\u2019s disease? Philos Trans R Soc Lond B Biol Sci. 2015;370:20140184.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"6020_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","volume":"9","author":"P Calabresi","year":"2010","unstructured":"Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B. Levodopa-induced dyskinesias in patients with Parkinson\u2019s disease: filling the bench-to-bedside gap. Lancet Neurol. 2010;9:1106\u201317.","journal-title":"Lancet Neurol"},{"key":"6020_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fncel.2018.00485","volume":"12","author":"C Zheng","year":"2018","unstructured":"Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, et al. TRH analog, taltirelin protects dopaminergic neurons from neurotoxicity of MPTP and rotenone. Front Cell Neurosci. 2018;12:485.","journal-title":"Front Cell Neurosci"},{"key":"6020_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fncel.2018.00417","volume":"12","author":"C Zheng","year":"2018","unstructured":"Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, et al. TRH analog, taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect. Front Cell Neurosci. 2018;12:417.","journal-title":"Front Cell Neurosci"},{"key":"6020_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/1440-1681.13675","volume":"49","author":"T Ijiro","year":"2022","unstructured":"Ijiro T, Yaguchi A, Yokoyama A, Kiguchi S. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission. Clin Exp Pharmacol Physiol. 2022;49:950\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6020_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.neuron.2019.11.004","volume":"105","author":"G Stanley","year":"2020","unstructured":"Stanley G, Gokce O, Malenka RC, S\u00fcdhof TC, Quake SR. Continuous and discrete neuron types of the adult murine striatum. Neuron. 2020;105:688-699.e8.","journal-title":"Neuron"},{"key":"6020_CR24","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1523\/JNEUROSCI.0195-15.2015","volume":"35","author":"HS Xenias","year":"2015","unstructured":"Xenias HS, Ib\u00e1\u00f1ez-Sandoval O, Ko\u00f3s T, Tepper JM. Are striatal tyrosine hydroxylase interneurons dopaminergic? J Neurosci. 2015;35:6584\u201399.","journal-title":"J Neurosci"},{"key":"6020_CR25","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1073\/pnas.1514074113","volume":"113","author":"M Uchigashima","year":"2016","unstructured":"Uchigashima M, Ohtsuka T, Kobayashi K, Watanabe M. Dopamine synapse is a neuroligin-2\u2013mediated contact between dopaminergic presynaptic and GABAergic postsynaptic structures. Proc Natl Acad Sci USA. 2016;113:4206\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6020_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-01088-0","volume":"8","author":"Z Li","year":"2022","unstructured":"Li Z, Shang Z, Sun M, Jiang X, Tian Y, Yang L, et al. Transcription factor Sp9 is a negative regulator of D1-type MSN development. Cell Death Discov. 2022;8:1\u201312.","journal-title":"Cell Death Discov"},{"key":"6020_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250:1429\u201332.","journal-title":"Science"},{"key":"6020_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/1570159X14666151201185652","volume":"14","author":"N Morin","year":"2016","unstructured":"Morin N, Morissette M, Gr\u00e9goire L, Di Paolo T. mGlu5, dopamine D 2 and adenosine A 2A receptors in L-DOPA-induced dyskinesias. CN. 2016;14:481\u201393.","journal-title":"CN"},{"key":"6020_CR29","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41467-020-15716-9","volume":"11","author":"E Puighermanal","year":"2020","unstructured":"Puighermanal E, Castell L, Esteve-Codina A, Melser S, Kaganovsky K, Zussy C, et al. Functional and molecular heterogeneity of D2R neurons along dorsal ventral axis in the striatum. Nat Commun. 2020;11:1957.","journal-title":"Nat Commun"},{"key":"6020_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00112","author":"G Chen","year":"2017","unstructured":"Chen G, Nie S, Han C, Ma K, Xu Y, Zhang Z, et al. Antidyskinetic effects of MEK inhibitor are associated with multiple neurochemical alterations in the striatum of hemiparkinsonian rats. Front Neurosci. 2017. https:\/\/doi.org\/10.3389\/fnins.2017.00112.","journal-title":"Front Neurosci"},{"key":"6020_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-8993(95)00690-R","volume":"692","author":"RC Boldry","year":"1995","unstructured":"Boldry RC, Papa SM, Kask AM, Chase TN. MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior. Brain Res. 1995;692:259\u201364.","journal-title":"Brain Res"},{"key":"6020_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/syn.20410","volume":"61","author":"A Pinna","year":"2007","unstructured":"Pinna A, Pontis S, Borsini F, Morelli M. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease. Synapse. 2007;61:606\u201314.","journal-title":"Synapse"},{"key":"6020_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix120","volume":"7","author":"Y Chen","year":"2018","unstructured":"Chen Y, Chen Y, Shi C, Huang Z, Zhang Y, Li S, et al. SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data. Gigascience. 2018;7:1\u20136.","journal-title":"Gigascience"},{"key":"6020_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"6020_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"key":"6020_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/bioinformatics\/btp612","volume":"26","author":"L Wang","year":"2010","unstructured":"Wang L, Feng Z, Wang X, Wang X, Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics. 2010;26:136\u20138.","journal-title":"Bioinformatics"},{"key":"6020_CR37","doi-asserted-by":"publisher","first-page":"14349","DOI":"10.1073\/pnas.94.26.14349","volume":"94","author":"TA Samad","year":"1997","unstructured":"Samad TA, Krezel W, Chambon P, Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor\u2013retinoid X receptor family. Proc Natl Acad Sci USA. 1997;94:14349\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6020_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJM. The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegeneration. 2017;12:10.","journal-title":"Mol Neurodegeneration"},{"key":"6020_CR39","first-page":"353","volume":"48","author":"I Fukuchi","year":"1998","unstructured":"Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, et al. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Arzneimittelforschung. 1998;48:353\u20139.","journal-title":"Arzneimittelforschung"},{"key":"6020_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1600-0773.1996.tb00230.x","volume":"78","author":"Y Itoh","year":"1996","unstructured":"Itoh Y, Yamazaki A, Ukai Y, Yoshikuni Y, Kimura K. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats. Pharmacol Toxicol. 1996;78:421\u20138.","journal-title":"Pharmacol Toxicol"},{"key":"6020_CR41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41422-022-00641-x","volume":"32","author":"Y Xu","year":"2022","unstructured":"Xu Y, Cai H, You C, He X, Yuan Q, Jiang H, et al. Structural insights into ligand binding and activation of the human thyrotropin-releasing hormone receptor. Cell Res. 2022;32:855\u20137.","journal-title":"Cell Res"},{"key":"6020_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/bbrc.1993.2027","volume":"195","author":"V Matre","year":"1993","unstructured":"Matre V, Karlsen HE, Wright MS, Lundell I, Fjeldheim AK, Gabrielsen OS, et al. Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Biophys Res Commun. 1993;195:179\u201385.","journal-title":"Biochem Biophys Res Commun"},{"key":"6020_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.981452","volume":"10","author":"R Trubacova","year":"2022","unstructured":"Trubacova R, Drastichova Z, Novotny J. Biochemical and physiological insights into TRH receptor-mediated signaling. Front Cell Dev Biol. 2022;10: 981452.","journal-title":"Front Cell Dev Biol"},{"key":"6020_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2379-5","volume":"584","author":"J Yin","year":"2020","unstructured":"Yin J, Chen K-YM, Clark MJ, Hijazi M, Kumari P, Bai X, et al. Structure of a D2 dopamine receptor-G protein complex in a lipid membrane. Nature. 2020;584:125\u20139.","journal-title":"Nature"},{"key":"6020_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1460-9568.2008.06040.x","volume":"27","author":"S Darmopil","year":"2008","unstructured":"Darmopil S, Mu\u00f1et\u00f3n-G\u00f3mez VC, de Ceballos ML, Bernson M, Moratalla R. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by l-DOPA. Eur J Neurosci. 2008;27:580\u201392.","journal-title":"Eur J Neurosci"},{"key":"6020_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","volume":"28","author":"P Arlotta","year":"2008","unstructured":"Arlotta P, Molyneaux BJ, Jabaudon D, Yoshida Y, Macklis JD. Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J Neurosci. 2008;28:622\u201332.","journal-title":"J Neurosci"},{"key":"6020_CR47","doi-asserted-by":"publisher","first-page":"12315","DOI":"10.18632\/aging.102574","volume":"11","author":"X-R Zhang","year":"2019","unstructured":"Zhang X-R, Zhang Z-R, Chen S-Y, Wang W-W, Wang X-S, He J-C, et al. \u03b2-arrestin2 alleviates L-dopa-induced dyskinesia via lower D1R activity in Parkinson\u2019s rats. Aging (Albany NY). 2019;11:12315\u201327.","journal-title":"Aging (Albany NY)"},{"key":"6020_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.783893","volume":"14","author":"S Gao","year":"2022","unstructured":"Gao S, Gao R, Yao L, Feng J, Liu W, Zhou Y, et al. Striatal D1 dopamine neuronal population dynamics in a rat model of levodopa-induced dyskinesia. Front Aging Neurosci. 2022;14: 783893.","journal-title":"Front Aging Neurosci"},{"key":"6020_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnbeh.2011.00071","volume":"5","author":"M Feyder","year":"2011","unstructured":"Feyder M, Bonito-Oliva A, Fisone G. L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine d1 receptor-mediated transmission. Front Behav Neurosci. 2011;5:71.","journal-title":"Front Behav Neurosci"},{"key":"6020_CR50","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/syn.20481","volume":"62","author":"J Lee","year":"2008","unstructured":"Lee J, Gomez-Ramirez J, Johnston TH, Visanji N, Brotchie JM. Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesioned rat model of Parkinson\u2019s disease. Synapse. 2008;62:310\u20133.","journal-title":"Synapse"},{"key":"6020_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.04.025","author":"S Darmopil","year":"2009","unstructured":"Darmopil S, Mart\u00edn AB, Diego IRD, Ares S, Moratalla R. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biolog Psychiatry. 2009. https:\/\/doi.org\/10.1016\/j.biopsych.2009.04.025.","journal-title":"Biolog Psychiatry"},{"key":"6020_CR52","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1517\/14728222.10.4.515","volume":"10","author":"P Seeman","year":"2006","unstructured":"Seeman P. Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets. 2006;10:515\u201331.","journal-title":"Expert Opin Ther Targets"},{"key":"6020_CR53","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jcb.21530","volume":"102","author":"AL Fields","year":"2007","unstructured":"Fields AL, Soprano DR, Soprano KJ. Retinoids in biological control and cancer. J Cell Biochem. 2007;102:886\u201398.","journal-title":"J Cell Biochem"},{"key":"6020_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"X-H Tang","year":"2011","unstructured":"Tang X-H, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol Mech Dis. 2011;6:345\u201364.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"6020_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcp.22417","volume":"226","author":"LJ Gudas","year":"2011","unstructured":"Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. J Cell Physiol. 2011;226:322\u201330.","journal-title":"J Cell Physiol"},{"key":"6020_CR56","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1073\/pnas.91.16.7772","volume":"91","author":"P McCaffery","year":"1994","unstructured":"McCaffery P, Dr\u00e4ger UC. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci USA. 1994;91:7772\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6020_CR57","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/jnc.12620","volume":"129","author":"J Ransom","year":"2014","unstructured":"Ransom J, Morgan PJ, McCaffery PJ, Stoney PN. The rhythm of retinoids in the brain. J Neurochem. 2014;129:366\u201376.","journal-title":"J Neurochem"},{"key":"6020_CR58","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1242\/dev.02865","volume":"134","author":"FMJ Jacobs","year":"2007","unstructured":"Jacobs FMJ, Smits SM, Noorlander CW, Von Oerthel L, Van Der Linden AJA, Burbach JPH, et al. Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development. 2007;134:2673\u201384.","journal-title":"Development"},{"key":"6020_CR59","doi-asserted-by":"publisher","first-page":"13671","DOI":"10.1038\/s41598-017-13826-x","volume":"7","author":"A Podle\u015bny-Drabiniok","year":"2017","unstructured":"Podle\u015bny-Drabiniok A, Sobska J, De Lera AR, Go\u0142embiowska K, Kami\u0144ska K, Doll\u00e9 P, et al. Distinct retinoic acid receptor (RAR) isotypes control differentiation of embryonal carcinoma cells to dopaminergic or striatopallidal medium spiny neurons. Sci Rep. 2017;7:13671.","journal-title":"Sci Rep"},{"key":"6020_CR60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2020.05.037","volume":"107","author":"S Brignani","year":"2020","unstructured":"Brignani S, Raj DDA, Schmidt ERE, D\u00fcd\u00fckc\u00fc \u00d6, Adolfs Y, De Ruiter AA, et al. Remotely produced and axon-derived netrin-1 instructs Gabaergic neuron migration and dopaminergic substantia Nigra development. Neuron. 2020;107:684-702.e9.","journal-title":"Neuron"},{"key":"6020_CR61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5483\/BMBRep.2023-0004","volume":"56","author":"EJ Kang","year":"2023","unstructured":"Kang EJ, Jang SM, Lee YJ, Jeong YJ, Kim YJ, Kang SS, et al. The couple of netrin-1\/\u03b1-Synuclein regulates the survival of dopaminergic neurons via \u03b1-Synuclein disaggregation. BMB Rep. 2023;56:126\u201331.","journal-title":"BMB Rep"},{"key":"6020_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103396","volume":"9","author":"G Chen","year":"2022","unstructured":"Chen G, Ahn EH, Kang SS, Xia Y, Liu X, Zhang Z, et al. UNC5C receptor proteolytic cleavage by active AEP promotes dopaminergic neuronal degeneration in Parkinson\u2019s disease. Adv Sci (Weinh). 2022;9: e2103396.","journal-title":"Adv Sci (Weinh)"},{"key":"6020_CR63","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105537","volume":"40","author":"M Jasmin","year":"2021","unstructured":"Jasmin M, Ahn EH, Voutilainen MH, Fombonne J, Guix C, Viljakainen T, et al. Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson\u2019s disease features. EMBO J. 2021;40: e105537.","journal-title":"EMBO J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-06020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-06020-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-06020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T20:02:06Z","timestamp":1735588926000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-06020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6020"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-06020-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1158"}}